Completed PHASE2 INTERVENTIONAL 2-arm NCT01185795

Efficacy of Cardioviva™ Probiotic Yogurt Formulation

Efficacy of a Microencapsulated Probiotic Yogurt Formulation as a Health Promoting Agent

Sponsor: Micropharma Limited

Interventions Cardioviva™ yogurt Placebo yogurt

Updated 5 times since 2017 Last updated: Jun 29, 2012 Started: Sep 30, 2008 Primary completion: Jan 31, 2009 Completion: Apr 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Hypercholesterolemia and is currently completed. Micropharma Limited leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Micropharma Limited

Data source: Micropharma Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.